OptimizeRx (OPRX) Net Margin (2016 - 2025)
Historic Net Margin for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to 2.99%.
- OptimizeRx's Net Margin rose 458100.0% to 2.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.41%, marking a year-over-year increase of 404400.0%. This contributed to the annual value of 21.83% for FY2024, which is 27300.0% up from last year.
- According to the latest figures from Q3 2025, OptimizeRx's Net Margin is 2.99%, which was up 458100.0% from 5.25% recorded in Q2 2025.
- OptimizeRx's Net Margin's 5-year high stood at 14.6% during Q4 2024, with a 5-year trough of 49.2% in Q1 2023.
- Over the past 5 years, OptimizeRx's median Net Margin value was 17.54% (recorded in 2023), while the average stood at 16.01%.
- In the last 5 years, OptimizeRx's Net Margin tumbled by -397300bps in 2023 and then surged by 559800bps in 2024.
- OptimizeRx's Net Margin (Quarter) stood at 3.07% in 2021, then plummeted by -154bps to 1.66% in 2022, then plummeted by -2396bps to 41.38% in 2023, then skyrocketed by 135bps to 14.6% in 2024, then tumbled by -80bps to 2.99% in 2025.
- Its Net Margin stands at 2.99% for Q3 2025, versus 5.25% for Q2 2025 and 10.03% for Q1 2025.